Oramed Pharmaceuticals (ORMP) Q2 2026 Earnings

May 19Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.19
0.18
0.54
0.91

Details

Expected EPS
N/A
Actual EPS
0.91
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Oramed Pharmaceuticals⁩ (⁦ORMP⁩) has reported earnings of ⁦0.91⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts